These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 16380253

  • 1. Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane.
    Jung M, Tak J, Chung WY, Park KK.
    Bioorg Med Chem Lett; 2006 Mar 01; 16(5):1227-30. PubMed ID: 16380253
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and antiangiogenic activity of thioacetal artemisinin derivatives.
    Oh S, Jeong IH, Ahn CM, Shin WS, Lee S.
    Bioorg Med Chem; 2004 Jul 15; 12(14):3783-90. PubMed ID: 15210144
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and antiangiogenic activity of exo-olefinated deoxoartemisinin derivatives.
    Oh S, Jeong IH, Shin WS, Lee S.
    Bioorg Med Chem Lett; 2004 Jul 16; 14(14):3683-6. PubMed ID: 15203143
    [Abstract] [Full Text] [Related]

  • 4. Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer.
    Jung M, Lee S, Ham J, Lee K, Kim H, Kim SK.
    J Med Chem; 2003 Mar 13; 46(6):987-94. PubMed ID: 12620075
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and anticancer activity of novel amide derivatives of non-acetal deoxoartemisinin.
    Jung M, Park N, Moon HI, Lee Y, Chung WY, Park KK.
    Bioorg Med Chem Lett; 2009 Nov 15; 19(22):6303-6. PubMed ID: 19819696
    [Abstract] [Full Text] [Related]

  • 6. Synthesis of daumone derivatives and their antiangiogenic activities on chorioallantoic membrane.
    Ricci J, Min D, Oh M, Lim H, Chung WY, Park KK, Jung M.
    Med Chem; 2015 Nov 15; 11(8):747-52. PubMed ID: 25974079
    [Abstract] [Full Text] [Related]

  • 7. Concise synthesis and antiangiogenic activity of artemisinin-glycolipid hybrids on chorioallantoic membranes.
    Ricci J, Park J, Chung WY, Park KK, Jung M.
    Bioorg Med Chem Lett; 2010 Nov 15; 20(22):6858-60. PubMed ID: 20855209
    [Abstract] [Full Text] [Related]

  • 8. Semisynthesis and pharmacological activities of Tetrac analogs: angiogenesis modulators.
    Bridoux A, Cui H, Dyskin E, Yalcin M, Mousa SA.
    Bioorg Med Chem Lett; 2009 Jun 15; 19(12):3259-63. PubMed ID: 19427201
    [Abstract] [Full Text] [Related]

  • 9. Facile synthesis and anticancer activity of C-10 non-acetal deoxoartemisinin dimers.
    Phothongkam S, Chancharunee S, Saovapakhiran A, Wichai U, Pohmakotr M.
    Bioorg Med Chem Lett; 2012 Dec 15; 22(24):7598-601. PubMed ID: 23103096
    [Abstract] [Full Text] [Related]

  • 10. Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10beta-(2-hydroxyethyl)deoxoartemisinin.
    Jeyadevan JP, Bray PG, Chadwick J, Mercer AE, Byrne A, Ward SA, Park BK, Williams DP, Cosstick R, Davies J, Higson AP, Irving E, Posner GH, O'Neill PM.
    J Med Chem; 2004 Feb 26; 47(5):1290-8. PubMed ID: 14971909
    [Abstract] [Full Text] [Related]

  • 11. Hydroxylation of 10-deoxoartemisinin by Cunninghamella elegans.
    Parshikov IA, Muraleedharan KM, Miriyala B, Avery MA, Williamson JS.
    J Nat Prod; 2004 Sep 26; 67(9):1595-7. PubMed ID: 15387669
    [Abstract] [Full Text] [Related]

  • 12. Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo.
    Lu J, Chong CR, Hu X, Liu JO.
    J Med Chem; 2006 Sep 21; 49(19):5645-8. PubMed ID: 16970390
    [Abstract] [Full Text] [Related]

  • 13. Synthesis of nοvel artemisinin dimers with polyamine linkers and evaluation of their potential as anticancer agents.
    Magoulas GE, Tsigkou T, Skondra L, Lamprou M, Tsoukala P, Kokkinogouli V, Pantazaka E, Papaioannou D, Athanassopoulos CM, Papadimitriou E.
    Bioorg Med Chem; 2017 Jul 15; 25(14):3756-3767. PubMed ID: 28549888
    [Abstract] [Full Text] [Related]

  • 14. TX-2152: a conformationally rigid and electron-rich diyne analogue of FTY720 with in vivo antiangiogenic activity.
    Nakayama S, Uto Y, Tanimoto K, Okuno Y, Sasaki Y, Nagasawa H, Nakata E, Arai K, Momose K, Fujita T, Hashimoto T, Okamoto Y, Asakawa Y, Goto S, Hori H.
    Bioorg Med Chem; 2008 Aug 15; 16(16):7705-14. PubMed ID: 18678496
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and evaluation of graveoline and graveolinine derivatives with potent anti-angiogenesis activities.
    An ZY, Yan YY, Peng D, Ou TM, Tan JH, Huang SL, An LK, Gu LQ, Huang ZS.
    Eur J Med Chem; 2010 Sep 15; 45(9):3895-903. PubMed ID: 20554355
    [Abstract] [Full Text] [Related]

  • 16. NMR studies on novel antitumor drug candidates, deoxoartemisinin and carboxypropyldeoxoartemisinin.
    Lee CH, Hong H, Shin J, Jung M, Shin I, Yoon J, Lee W.
    Biochem Biophys Res Commun; 2000 Aug 02; 274(2):359-69. PubMed ID: 10913344
    [Abstract] [Full Text] [Related]

  • 17. 5'-O-tritylated nucleoside derivatives: inhibition of thymidine phosphorylase and angiogenesis.
    Liekens S, Bronckaers A, Hernández AI, Priego EM, Casanova E, Camarasa MJ, Pérez-Pérez MJ, Balzarini J.
    Mol Pharmacol; 2006 Aug 02; 70(2):501-9. PubMed ID: 16675660
    [Abstract] [Full Text] [Related]

  • 18. Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis.
    Chen W, Lu Y, Wu J, Gao M, Wang A, Xu B.
    Cancer Chemother Pharmacol; 2011 Apr 02; 67(4):799-808. PubMed ID: 20563582
    [Abstract] [Full Text] [Related]

  • 19. Identification of campesterol from Chrysanthemum coronarium L. and its antiangiogenic activities.
    Choi JM, Lee EO, Lee HJ, Kim KH, Ahn KS, Shim BS, Kim NI, Song MC, Baek NI, Kim SH.
    Phytother Res; 2007 Oct 02; 21(10):954-9. PubMed ID: 17604370
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.